Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Lint

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Clinical and Experimental Immunology|September 16, 1998
Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP)C Suankratay, C Mold, Y Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1975
Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycationsP J Baker, T F Lint, B C McLeod, et al.
Immunology|January 1, 1992
Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected personsR A June, A L Landay, K Stefanik, et al.
Immunology|August 1, 1991
Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysisG T Spear, B L Sullivan, D M Takefman, et al.
Clinical and Experimental Immunology|November 23, 2007
L-ficolin binding and lectin pathway activation by acetylated low-density lipoproteinJ Faro, Y Chen, P Jhaveri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1979
Activation of human complement by liposomes: a model for membrane activation of the alternative pathwayC M Cunningham, M Kingzette, R L Richards, et al.
AIDS Research and Human Retroviruses|July 1, 1991
Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cellsG T Spear, H X Jiang, B L Sullivan, et al.
Neurology|May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's diseaseP M Carvey, A McRae, T F Lint, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1981
The role of C9 in complement-mediated killing of NeisseriaG R Harriman, A F Esser, E R Podack, et al.
AIDS (London, England)|March 1, 1991
Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formationR A June, S Z Schade, M J Bankowski, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Clinical and Experimental Immunology|September 16, 1998
Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP)C Suankratay, C Mold, Y Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1975
Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycationsP J Baker, T F Lint, B C McLeod, et al.
Immunology|January 1, 1992
Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected personsR A June, A L Landay, K Stefanik, et al.
Immunology|August 1, 1991
Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysisG T Spear, B L Sullivan, D M Takefman, et al.
Clinical and Experimental Immunology|November 23, 2007
L-ficolin binding and lectin pathway activation by acetylated low-density lipoproteinJ Faro, Y Chen, P Jhaveri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1979
Activation of human complement by liposomes: a model for membrane activation of the alternative pathwayC M Cunningham, M Kingzette, R L Richards, et al.
AIDS Research and Human Retroviruses|July 1, 1991
Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cellsG T Spear, H X Jiang, B L Sullivan, et al.
Neurology|May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's diseaseP M Carvey, A McRae, T F Lint, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1981
The role of C9 in complement-mediated killing of NeisseriaG R Harriman, A F Esser, E R Podack, et al.
AIDS (London, England)|March 1, 1991
Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formationR A June, S Z Schade, M J Bankowski, et al.
Pageof 6